Market Access

7th Annual IMPACCT: Real World Evidence

https://pharmaphorum.com/events/7th-annual-impacct-real-world-evidence/

Vertex presses go on its cystic fibrosis triple filing

https://pharmaphorum.com/news/vertex-presses-go-on-its-cystic-fibrosis-triple-filing/

Biohaven ALS drug blocked by FDA over manufacturing issue

https://pharmaphorum.com/news/biohaven-als-drug-blocked-by-fda-over-manufacturing-issue/

NICE reviews number crunching methods as advanced technologies hit market

https://pharmaphorum.com/news/nice-reviews-number-crunching-methods-as-advanced-technologies-hit-market/

Roche under pressure in US as Amgen/Allergan launch US cancer biosimilars

https://pharmaphorum.com/news/roche-under-pressure-in-us-as-amgen-allergan-launch-us-cancer-biosimilars/

Who will pay the price for inaction on superbugs?

https://pharmaphorum.com/r-d/views-analysis-r-d/who-will-pay-the-price-for-inaction-on-superbugs/

Three Interactive Sessions to take place at the Respiratory Drug Delivery Conference

https://pharmaphorum.com/partner-content/three-interactive-sessions-to-take-place-at-the-respiratory-drug-delivery-conference/

FDA clears Bayer’s Gadavist as first contrast agent for cardiac MRI

https://pharmaphorum.com/news/fda-clears-bayers-gadavist-as-first-contrast-agent-for-cardiac-mri/

NICE numbers at 20

https://pharmaphorum.com/views-analysis-market-access/nice-numbers-20/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search